32 related articles for article (PubMed ID: 38567708)
1. Icaritin-induced immunomodulatory efficacy in advanced hepatitis B virus-related hepatocellular carcinoma: Immunodynamic biomarkers and overall survival.
Qin SK; Li Q; Ming Xu J; Liang J; Cheng Y; Fan Y; Jiang J; Ye H; Tao H; Li L; Zheng L; Wei Z; Li S; Meng K; Ye B; Sun Y
Cancer Sci; 2020 Nov; 111(11):4218-4231. PubMed ID: 32889778
[TBL] [Abstract][Full Text] [Related]
2. Icaritin Induces Anti-tumor Immune Responses in Hepatocellular Carcinoma by Inhibiting Splenic Myeloid-Derived Suppressor Cell Generation.
Tao H; Liu M; Wang Y; Luo S; Xu Y; Ye B; Zheng L; Meng K; Li L
Front Immunol; 2021; 12():609295. PubMed ID: 33717093
[TBL] [Abstract][Full Text] [Related]
3. First-in-class immune-modulating small molecule Icaritin in advanced hepatocellular carcinoma: preliminary results of safety, durable survival and immune biomarkers.
Fan Y; Li S; Ding X; Yue J; Jiang J; Zhao H; Hao R; Qiu W; Liu K; Li Y; Wang S; Zheng L; Ye B; Meng K; Xu B
BMC Cancer; 2019 Mar; 19(1):279. PubMed ID: 30922248
[TBL] [Abstract][Full Text] [Related]
4. Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma.
Li H; Liu Y; Jiang W; Xue J; Cheng Y; Wang J; Yang R; Zhang X
BMC Cancer; 2021 Mar; 21(1):318. PubMed ID: 33765973
[TBL] [Abstract][Full Text] [Related]
5. New insights into the anticancer therapeutic potential of icaritin and its synthetic derivatives.
Reyes-Hernández OD; Figueroa-González G; Quintas-Granados LI; Hernández-Parra H; Peña-Corona SI; Cortés H; Kipchakbayeva A; Mukazhanova Z; Habtemariam S; Leyva-Gómez G; Büsselberg D; Sharifi-Rad J
Drug Dev Res; 2024 Apr; 85(2):e22175. PubMed ID: 38567708
[TBL] [Abstract][Full Text] [Related]
6. Molecular and cellular basis of the anticancer activity of the prenylated flavonoid icaritin in hepatocellular carcinoma.
Bailly C
Chem Biol Interact; 2020 Jul; 325():109124. PubMed ID: 32437694
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effects of icaritin and the molecular mechanisms.
Zhang C; Sui X; Jiang Y; Wang X; Wang S
Discov Med; 2020; 29(156):5-16. PubMed ID: 32598859
[TBL] [Abstract][Full Text] [Related]
8. Icaritin: A Novel Natural Candidate for Hematological Malignancies Therapy.
Yang XJ; Xi YM; Li ZJ
Biomed Res Int; 2019; 2019():4860268. PubMed ID: 31032347
[TBL] [Abstract][Full Text] [Related]
9. Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.
Xing R; Gao J; Cui Q; Wang Q
Front Immunol; 2021; 12():783236. PubMed ID: 34899747
[TBL] [Abstract][Full Text] [Related]
10. Liver protecting effects and molecular mechanisms of icariin and its metabolites.
Ma Y; Zhao C; Hu H; Yin S
Phytochemistry; 2023 Nov; 215():113841. PubMed ID: 37660725
[TBL] [Abstract][Full Text] [Related]
11. New insights into the pharmacological, immunological, and CAR-T-cell approaches in the treatment of hepatocellular carcinoma.
Dal Bo M; De Mattia E; Baboci L; Mezzalira S; Cecchin E; Assaraf YG; Toffoli G
Drug Resist Updat; 2020 Jul; 51():100702. PubMed ID: 32371296
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]